Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
复制标题
肿瘤浸润的调节性T细胞抑制内源性细胞毒性T细胞对肺腺癌的反应。
DOI:
10.4049/jimmunol.1301317
复制
发表时间:
2013-08-15
期刊:
影响因子:
--
通讯作者:
Coussens LM
中科院分区:
文献类型:
--
作者:
Ganesan AP;Johansson M;Ruffell B;Yagui-Beltrán A;Lau J;Jablons DM;Coussens LM
Immune cells comprise a substantial proportion of the tumor mass in human non-small cell lung cancers (NSCLC), but the precise composition and significance of this infiltration is unclear. Herein we examined immune complexity of human NSCLC as well as NSCLC developing in CC10-TAg transgenic mice, and revealed that CD4+ T lymphocytes represent the dominant population of CD45+ immune cells, and relative to normal lung tissue, CD4+FoxP3+ regulatory T cells (Tregs) were significantly increased as a proportion of total CD4+ cells. To assess the functional significance of increased Treg cells, we evaluated CD8+ T cell-deficient/CC10-TAg mice and revealed that CD8+ T cells significantly controlled tumor growth with anti-tumor activity that was partially repressed by Treg cells. However, while treatment with anti-CD25 depleting mAb as monotherapy preferentially depleted Tregs and improved CD8+ T cell-mediated control of tumor progression during early tumor development, similar monotherapy was ineffective at later stages. Since mice bearing early NSCLC treated with anti-CD25 mAb exhibited increased tumor cell death associated with infiltration by CD8+ T cells expressing elevated levels of granzyme A, granzyme B, perforin and interferon-γ, we therefore evaluated carboplatin combination therapy resulting in a significantly extended survival beyond that observed with chemotherapy alone, indicating that Treg depletion in combination with cytotoxic therapy may be beneficial as a treatment strategy for advanced NSCLC.
登录
查看更多内容
影响因子:
11.2
作者:
Deeb, Kristin K.;Michalowska, Aleksandra M.;Green, Jeffrey E.
通讯作者:
Green, Jeffrey E.
DOI:
10.4049/jimmunol.0903009
发表时间:
2010-04-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
DiLillo DJ;Yanaba K;Tedder TF
通讯作者:
Tedder TF
影响因子:
13.6
作者:
Mahajan, Deepika;Wang, Yiping;Harris, David C. H.
通讯作者:
Harris, David C. H.
影响因子:
5.3
作者:
Johnson, SK;Kerr, KM;Jeffrey, RR
通讯作者:
Jeffrey, RR
影响因子:
15.3
作者:
Ghiringhelli, F;Ménard, C;Terme, M;Flament, C;Taieb, J;Chaput, N;Puig, PE;Novault, S;Escudier, B;Vivier, E;Lecesne, A;Robert, C;Blay, JY;Bernard, J;Caillat-Zucman, S;Freitas, A;Tursz, T;Wagner-Ballon, O;Capron, C;Vainchencker, W;Martin, F;Zitvogel, L
通讯作者:
Zitvogel, L